OXFORD IMMUNOTEC GLOBAL PLC
CIK 0001586049
Revenue (TTM)
$104.16M
+19.8% YoY
Q3 Oct 2020
Net Income (TTM)
−$15.14M
−101.5% YoY
Q3 Oct 2020
EPS Diluted (TTM)
−$0.33
−101.5% YoY
Q3 Oct 2020
Gross Margin
42.5%
Q3 Oct 2020
Operating Margin
-15.4%
Q3 Oct 2020
Net Margin
-14.5%
Q3 Oct 2020
Free Cash Flow (TTM)
−$51.85M
Q3 Oct 2020
Cash
$160.62M
Q3 Oct 2020
Total Debt
$30M
Q3 Oct 2020
Shares Outstanding
25.96M sh
Q3 Oct 2020